Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This early phase I trial studies the possible benefits and/or side effects of topical or oral minoxidil in treating endocrine therapy-induced hair loss (alopecia) in patients with stage I-IV breast cancer. Endocrine therapy-induced alopecia (EIA) is a distressing side effect that leads to reduced quality of life and early cessation of therapy in women undergoing treatment for breast cancer. Patients on endocrine therapy commonly report hair loss or thinning. Minoxidil is a drug that may promote hair growth and reduce hair loss. Oral minoxidil may increase hair density in women with EIA, and work the same as topical minoxidil in treating EIA in patients with breast cancer.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Kobieta w wieku 18 lat lub starszy
- •Potwierdzony diagnoza raka piersi (stadium I-IV)
- •Lecze hormonalnie tamoksyfenem lub inhibitorami aromatazy, z możliwością stosowania dodatkowych leków hamujących funkcję jajników
- •Samodzielnie zgłaszana utrata włosów od czasu rozpoczęcia leczenia hormonalnego
✗ Disqualifies
- •Kobieta w ciąży lub karmiąca piersią
- •Bieżąca chemioterapia lub jej stosowanie w ostatnich 2 latach
- •Historia bliznowatego wypadania włosów lub łysienia plackowatego
- •Poprzednie stosowanie minoksydylu w tabletkach lub maściach
- •Bieżące lub poprzednie stosowanie spironolaktonu
- •Znana wrażliwość na minoksydyl
- •Nieleczona niedoczynność tarczycy lub niedobór żelaza
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- March 10, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
Ohio State University Comprehensive Cancer Center
Columbus, United States
Trial contact
The Ohio State University Comprehensive Cancer Center
Contact information from ClinicalTrials.gov. Contact in English.
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.